Current Therapy of Cooley's Anemia
1990; Wiley; Volume: 612; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1990.tb24315.x
ISSN1749-6632
AutoresPatricia J. Giardina, R W Grady, Kathryn H. Ehlers, Suzanne R. Burstein, Joseph H. Graziano, Alicejane L Markenson, Margaret W. Hilgartner,
Tópico(s)Neuroblastoma Research and Treatments
ResumoAnnals of the New York Academy of SciencesVolume 612, Issue 1 p. 275-285 Current Therapy of Cooley's Anemia A Decade of Experience with Subcutaneous Desferrioxaminea P. J. GIARDINA, Corresponding Author P. J. GIARDINA Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Address correspondence to Patricia J. Giardina, M.D., Division of Pediatric Hematology/Oncology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, NY 10021.Search for more papers by this authorR. W. GRADY, R. W. GRADY Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this authorK. H. EHLERS, K. H. EHLERS Divisions of Pediatric Cardiology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this authorS. BURSTEIN, S. BURSTEIN Divisions of Pediatric Endocrinology Department of Pediatrics, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Lebonhuer Children's Medical Center, 848 Adams Avenue, Memphis, TN 38103.Search for more papers by this authorJ. H. GRAZIANO, J. H. GRAZIANO Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Department of Pharmacology, Columbia Presbyterian Medical Center, 630 West 168th Street, New York, NY 10032.Search for more papers by this authorA. L. MARKENSON, A. L. MARKENSON Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Merck & Co., P.O. Box 2000-RY-32-57, Rahway, NJ 07065.Search for more papers by this authorM. W. HILGARTNER, M. W. HILGARTNER Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this author P. J. GIARDINA, Corresponding Author P. J. GIARDINA Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Address correspondence to Patricia J. Giardina, M.D., Division of Pediatric Hematology/Oncology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, NY 10021.Search for more papers by this authorR. W. GRADY, R. W. GRADY Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this authorK. H. EHLERS, K. H. EHLERS Divisions of Pediatric Cardiology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this authorS. BURSTEIN, S. BURSTEIN Divisions of Pediatric Endocrinology Department of Pediatrics, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Lebonhuer Children's Medical Center, 848 Adams Avenue, Memphis, TN 38103.Search for more papers by this authorJ. H. GRAZIANO, J. H. GRAZIANO Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Department of Pharmacology, Columbia Presbyterian Medical Center, 630 West 168th Street, New York, NY 10032.Search for more papers by this authorA. L. MARKENSON, A. L. MARKENSON Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021 Current address: Merck & Co., P.O. Box 2000-RY-32-57, Rahway, NJ 07065.Search for more papers by this authorM. W. HILGARTNER, M. W. HILGARTNER Divisions of Pediatric Hematology/Oncology, The New York Hospital-Cornell University Medical College New York, New York 10021Search for more papers by this author First published: December 1990 https://doi.org/10.1111/j.1749-6632.1990.tb24315.xCitations: 12 a This work was supported by National Institute of Health Grants #19898–01 and RR-00047 from the General Clinical Research Centers Program Office of the Division of Research Resources Foundation, and by the Children's Blood Foundation. The support of HRI 815322OB for patient care is gratefully acknowledged. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Wolman, I. J. 1964. Transfusion therapy in Cooley's Anemia: Growth and health as related to long range hemoglobin levels—A progress report Ann. N.Y. Acad. Sci.. 119: 736–747. 10.1111/j.1749-6632.1965.tb54075.x CASPubMedWeb of Science®Google Scholar 2 Piomelli, S., S. J. Danoff, M. H. Becker, M. J. Lipera & S. F. Travis. 1969. Prevention of bone malformations and cardiomegaly in Cooley's anemia by early hypertransfusion regimen Ann. N.Y. Acad. Sci.. 165: 427–436. 10.1111/j.1749-6632.1969.tb27814.x CASPubMedWeb of Science®Google Scholar 3 Piomelli, S., M. H. Karpatkin, M. Arzanian, M. Zamani, M. H. Becker, N. Geneiser, S. J. Danoff & W. J. Kuhns. 1974. Hypertransfusion regimen in patients with Cooley's anemia Ann. N.Y. Acad. Sci.. 232: 186–192. 10.1111/j.1749-6632.1974.tb20584.x CASPubMedWeb of Science®Google Scholar 4 Propper, R. D., L. N. Button & D. G. Nathan. 1980. New approaches to the transfusion management of thalassemia Blood. 55: 55–60. 10.1182/blood.V55.1.55.55 CASPubMedWeb of Science®Google Scholar 5 De Alarcon, P. A., M. Donovan, G. B. Forbes, S. A. Landaw & J. A. Stockman III. 1979. Iron absorption in the thalassemia syndromes and its inhibition by tea N. Engl. J. Med.. 300: 5–8. 10.1056/NEJM197901043000102 PubMedWeb of Science®Google Scholar 6 Piomelli, S., J. Graziano, M. Karpatkin, G. G. Dudell, D. Hart, M. Hilgartner, K. Khanna, L. M. Valdez-Cruz & S. Vora. 1980. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients Ann. N.Y. Acad. Sci.. 344: 409–417. 10.1111/j.1749-6632.1980.tb33680.x CASPubMedGoogle Scholar 7 Piomelli, S., D. Hart, J. Graziano, G. Grant, M. Karpatkin & K. McCarthy. 1985. Current strategies in the management of Cooley's anemia Ann. N.Y. Acad. Sci.. 445: 256–267. 10.1111/j.1749-6632.1985.tb17195.x CASPubMedWeb of Science®Google Scholar 8 Kikugawa, K. & K. Minoshima. 1978. Filter columns for preparation of leukocyte-poor blood for transfusion Vox Sang.. 34: 281–290. 10.1111/j.1423-0410.1978.tb02483.x CASPubMedWeb of Science®Google Scholar 9 Meryman, H. T. & M. Hornblower. 1986. The preparation of red cells depleted of leukocytes Transfusion. 26: 101–106. 10.1046/j.1537-2995.1986.26186124010.x CASPubMedWeb of Science®Google Scholar 10 Graziano, J. H., S. Piomelli, M. Hilgartner, P. Giardina, M. A. Karpatkin, M. Andrew, N. LoIacono & C. Seamon. 1981. Chelation therapy in β-thalassemia major: III The role of splenectomy in achieving iron balance. J. Pediatr.. 99: 695–699. CASPubMedWeb of Science®Google Scholar 11 Smith, C. H., M. E. Erlandson, G. Stern & M. W. Hilgartner. 1964. Postsplenectomy infection in Cooley's anemia Ann. N.Y. Acad. Sci.. 119: 748–757. 10.1111/j.1749-6632.1965.tb54076.x CASPubMedWeb of Science®Google Scholar 12 Akbar, A. N., P. A. Fitzgeral-Bocarsly, M. De Sousa, P. J. Giardina, M. W. Hilgartner & R. Grady. 1986. Decreased natural killer activity in thalassemia major: A possible consequence of iron overload J. Immunol.. 136: 1635–1640. 10.4049/jimmunol.136.5.1635 CASPubMedWeb of Science®Google Scholar 13 Smith, R. S. 1964. Chelating agents in the diagnosis and treatment of iron overload in thalassemia Ann. N.Y. Acad. Sci.. 119: 776–788. 10.1111/j.1749-6632.1965.tb54079.x CASPubMedWeb of Science®Google Scholar 14 Graziano, J. H., A. J. Markenson, D. R. Miller, H. Chang, M. Bestak, P. Meyers, P. Pisciotto & A. Rifkind. 1978. Chelation therapy in β-thalassemia major: I Intravenous and subcutaneous desferoxamine. J. Pediatr.. 92: 648–652. CASPubMedWeb of Science®Google Scholar 15 Propper, R. D., B. Cooper, R. R. Rufo, A. W. Nienhuis, W. F. Anderson, H. F. Bunn, A. Rosenthal & D. G. Nathan. 1977. Continuous subcutaneous administration of deferoxamine in patients with iron overload N. Engl. J. Med.. 297: 418–423. 10.1056/NEJM197708252970804 PubMedWeb of Science®Google Scholar 16 Pippard, M. J., S. T. Callender & C. A. Finch. 1982. Feroxamine excretion in iron loaded man Blood. 60: 288–294. PubMedWeb of Science®Google Scholar 17 De Virgiliis, S., M. Congia, F. Frau, F. Argiolu, G. Diana, F. Cucca, A. Varsi, G. Sanna, G. Podda, M. Fodde, G. F. Pirastu & A. Cao. 1988. Deferoxamine-induced growth retardation in patients with thalassemia major J. Pediatr.. 113: 661–669. 10.1016/S0022-3476(88)80375-5 PubMedWeb of Science®Google Scholar 18 Giardina, P. J., P. DelBalzo, R. W. Grady, J. M. Gertner, M. I. New & M. W. Hilgartner. 1988. Improved growth in homozygous beta thalassemia with hypertransfusion and chelation therapy Blood. 72(Suppl. 1): 61a. Google Scholar 19 Brill, P. W., P. Winchester, P. J. Giardina, S. Cunningham-Rundles. 1990. Acquired bone dysplasia in thalassemia major. Am. J. Radiol. Manuscript submitted. Google Scholar 20 Olivieri, N. F., J. R. Buncic, E. Chew, T. Gallant, R. V. Harrison, N. Keenan, W. Logan, D. Mitchell, G. Ricci, B. Skarf, M. Taylor & M. H. Freedman. 1984. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions N. Engl. J. Med.. 314: 869–873. 10.1056/NEJM198604033141402 PubMedWeb of Science®Google Scholar 21 Nienhuis, A. W. 1981. Vitamin C & iron N. Engl. J. Med.. 304: 170–171. 10.1056/NEJM198101153040311 PubMedWeb of Science®Google Scholar 22 Cohen, A. R., J. Mizanin & E. Schwartz. 1989. Rapid removal of excessive iron with daily high dose intravenous chelation therapy J. Pediatr.. 115: 151–155. 10.1016/S0022-3476(89)80353-1 PubMedWeb of Science®Google Scholar 23 Brittenham, G. M., P. M. Griffith & A. W. Nienhuis. 1988. Desferrioxamine use protects against heart disease and death from transfusional overload in thalassemia major Blood. 72(Suppl. 1): 56a. Google Scholar 24 Ehlers, K. H., P. J. Giardina, R. W. Grady, M. A. Engle & M. W. Hilgartner. 1990. Improved survival in thalassemia major. J. Pediatr. In press. Google Scholar Citing Literature Volume612, Issue1Sixth Cooley's Anemia SymposiumDecember 1990Pages 275-285 ReferencesRelatedInformation
Referência(s)